Travel grant 2024 Switzerland, Swiss Nordic Bio 2024 on March 7
| Reference number | |
| Coordinator | Pharmnovo AB |
| Funding from Vinnova | SEK 14 182 |
| Project duration | March 2024 - March 2024 |
| Status | Completed |
| Venture | Global cooperation 2024 |
Important results from the project
The goal of building contacts with both investors and pharma companies has been fulfilled.
Expected long term effects
three investor meetings completed which are expected to lead to further discussion and possible negotiation.
Approach and implementation
follow-up is to be carried out with both investors and pharma companies via email and Team meetings over the next 1-2 months.